Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Low Back Pain With a Neuropathic Component”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Post-approval studies (Phase 4)Study completedNCT01166048
What this trial is testing

Comparison of the Efficacy of Duloxetine With Placebo in Patients With Chronic Low Back Pain With a Radicular Component

Who this might be right for
Chronic Low Back Pain
Medical University of Vienna 41
Not applicableLooking for participantsNCT07125027
What this trial is testing

A Multicomponent Intervention for Patients With Lumbosacral Radiculopathy: Move-MORE

Who this might be right for
Lumbosacral RadiculopathySciaticaChronic Low Back Pain With a Neuropathic Component+2 more
National University of Natural Medicine 32
Post-approval studies (Phase 4)Study completedNCT01352741
What this trial is testing

Comparison of Increasing Doses of Tapentadol Versus a Combination of Tapentadol and Pregabalin

Who this might be right for
Low Back PainNeuropathic Pain
Grünenthal GmbH 622
Post-approval studies (Phase 4)Ended earlyNCT01838044
What this trial is testing

Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component

Who this might be right for
Chronic Low Back Pain With a Neuropathic Component
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 180
Post-approval studies (Phase 4)Study completedNCT01838616
What this trial is testing

Tapentadol Prolonged Release (PR) Versus Oxycodone/Naloxone Prolonged Release in Severe Chronic Low Back Pain With a Neuropathic Component.

Who this might be right for
Back PainLow Back PainNeuropathic Pain
Grünenthal GmbH 367